drugset / Trial / NCT00446576

The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease

NCT00446576

Phase 3 Completed 176 enrolled Janssen-Cilag B.V.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess whether maintaining hemoglobin (Hb) levels at normal or sub-normal levels with Epoetin Alfa can influence the health status, left ventricular mass and quality of life of early renal insufficiency subjects without additional safety concerns.

Timeline

Start
1999-11
Primary completion
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic Subcutaneous

Indications